A comparison of the rapid-acting insulin analogue glulisine with lispro and aspart for the pump treatment of patients with type 1 diabetes-Reference-Cited by-同舟云学术

A comparison of the rapid-acting insulin analogue glulisine with lispro and aspart for the pump treatment of patients with type 1 diabetes

Published:2022-08-07 Issue:11 Volume:59 Page:1453-1460
ISSN:1432-5233
Container-title:Acta Diabetologica
language:en
Short-container-title:Acta Diabetol

Author:

Bramlage Peter^ORCID,Tittel Sascha R.^ORCID,Müther Silvia,Reinhart-Steininger Birgit,Haberland Holger,Khodaverdi Semik,Zimny Stefan,Ohlenschläger Ute,Lanzinger Stefanie^ORCID,Haak Thomas

Funder

Sanofi

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00592-022-01939-3.pdf

Reference33 articles.

1. Bergholtz CH, Olsen B, Johannesen J (2009) Insulin pump therapy in children and teenagers. Ugeskr Laeger 171(23):1913–1918

2. Pozzilli P et al (2016) Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics. Diabetes Metab Res Rev 32(1):21–39

3. Misso ML et al (2010) Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev 1:CD005103

4. Pickup JC (2012) Insulin-pump therapy for type 1 diabetes mellitus. N Engl J Med 366(17):1616–1624

5. Kaiserman K et al (2012) Continuous subcutaneous infusion of insulin lispro in children and adolescents with type 1 diabetes mellitus. Endocr Pract 18(3):418–424

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 100 Jahre Insulin: Wie hat sich die Insulintherapie bei Erwachsenen zwischen 2000 und 2021 verändert?;Diabetologie und Stoffwechsel;2023-04-21

2. Pumpentherapie bei Typ-1-Diabetes: Glulisin und Lispro/Aspart im Vergleich;Diabetologie und Stoffwechsel;2023-02

3. New Insulins, Biosimilars, and Insulin Therapy;Diabetes Technology & Therapeutics;2023-02-01